Bullous Pemphigoid and Dipeptidyl Peptidase-4 Inhibitors in Patients With Diabetes

This case-control study examines the association between the use of dipeptidyl peptidase 4 inhibitors and the risk of developing bullous pemphigoid in patients with diabetes.

http://bit.ly/2slBu0Z